We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Common, Rare and Somatic Genetic Drivers Together Double 5‑Year Atrial Fibrillation Risk: Toward an Integrated Genomic Model (IGM‑AF)

MedXY Editorial Team•Dec 3, 2025•Cardiology
atrial fibrillationClonal hematopoiesisgeneticspolygenic risk

Highlight

– Whole‑genome data from 416,085 UK Biobank participants show that polygenic risk, a composite rare‑variant gene set, and somatic clonal hematopoiesis (CHIP) each independently increase 5‑year incident atrial fibrillation (AF) risk.
– Individuals carrying all three genetic drivers had at least a two‑fold higher 5‑year AF cumulative incidence versus those with a single driver.
– Integrating the integrated genomic model for AF (IGM‑AF) with a clinical risk tool (CHARGE‑AF) raised the C‑statistic to 0.80 and produced a modest net reclassification improvement (NRI 0.08), supporting additive predictive value of comprehensive genomic profiling.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Genotype-Dependent Risk and Impact of Atrial Fibrillation in Dilated Cardiomyopathy: Insights from the SHaRe RegistryThis study reveals genotype-specific differences in atrial fibrillation (AF) risk among dilated cardiomyopathy (DCM) patients, highlighting LMNA mutations as a major predictor of incident AF and its association with worse clinical outcomes,Sep 15, 2026Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis: A Precision Medicine ImperativeClonal hematopoiesis of indeterminate potential (CHIP) poses a novel cardiovascular risk. This article explores challenges and strategies for designing cardiovascular outcomes trials tailored to CHIP’s genetic heterogeneity and clinical comSep 15, 2026Physiological Left Atrial Staging as a Predictor of New-Onset Atrial Fibrillation in Hypertrophic CardiomyopathyA novel left atrial (LA) staging system, integrating hemodynamic load and contractile function, predicts new-onset atrial fibrillation risk in hypertrophic cardiomyopathy and may guide tailored AF surveillance.Sep 15, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Expanding Horizons in Dilated Cardiomyopathy: A Comprehensive Genetic Reassessment in 2024
The 2024 update of the Clinical Genome Resource elucidates a rapidly expanding genetic landscape for dilated cardiomyopathy, enhancing clinical genetic interpretation with 35 genes classified as high evidence, including nine novel discoveri
Sep 12, 2026
Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial FibrillationThis study analyzes global trends comparing ischemic stroke burdens linked to diabetes and atrial fibrillation, revealing a rising impact of diabetes-related stroke and highlighting the need for targeted interventions.Sep 12, 2026
Clonal Hematopoiesis Dynamics in Aplastic Anemia Patients Undergoing Immunosuppressive Therapy: Insights and Clinical ImplicationsLongitudinal analysis of 371 aplastic anemia patients reveals distinct patterns of clonal hematopoiesis under immunosuppressive therapy, highlighting variable mutation dynamics, cytogenetic changes, and progression risks.Sep 11, 2026